Taken together, reduced class I-HLA ligands, together with increased ICAM-1/LFA-1 interactions within KIR2DL1 receptor might tip the threshold balance toward increased activation, effector target conjugation, and increased killing of GBM cells maintained in stem cell media. Here, ICAM1 is linked to glioblastoma.